XML 21 R5.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Equity - USD ($)
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Treasury Stock [Member]
Noncontrolling Interest [Member]
Retained Earnings [Member]
Balance at Dec. 31, 2020 $ 14,356,506 $ 1,342 $ 106,526,889 $ (2,157,225) $ (90,014,500)
Balance, shares at Dec. 31, 2020   1,341,735        
Stock-based compensation 1,605,949 1,605,949
Restricted common stock grant $ 43 (43)
Restricted common stock grant, shares   42,800        
Restricted common stock forfeitures
Restricted common stock forfeitures, shares   (385)        
Issuance of common stock under rule 144 restrictions related to contemplated spin-off transaction 6,729,000 $ 140 6,728,860
Issuance of common stock through registered direct offering at $3.095 per share and accompanying warrants (net of offering expenses and placement agent discount), shares   140,000        
Issuance of common stock through registered direct offering at $56.00 per share and accompanying warrants (net of offering expenses and placement agent discount) 6,617,600 $ 162 6,617,438
Issuance of common stock through registered direct offering at $2.80 per share and accompanying warrants (net of offering expenses and placement agent discount), shares   162,500        
Exercise of pre-funded common stock purchase warrants at $61.90 per share 22,284,000 $ 360 22,283,640
Exercise of pre-funded common stock purchase warrants at $3.095 per share, shares   360,000        
Exercise of pre-funded common stock purchase warrants at $56.00 per share 30,940,000 $ 552 30,939,448
Exercise of pre-funded common stock purchase warrants at $2.80 per share, shares   552,500        
Issuance of pre-funded common stock purchase warrants in connection with the registered direct offerings (1,817,548) (1,817,548)
Issuance of common stock purchase warrants at exercise price of $65.00 per share in connection with the registered direct offerings (49,398,510) (49,398,510)
Issuance of common stock as consideration for acquisition 990,360 $ 36 990,324
Issuance of common stock as consideration for acquisition, shares   35,987        
Repurchase and cancellation of common stock (1,975,079) $ (87) (1,974,992)
Repurchase and cancellation of common stock, shares   (86,742)        
Cancellation of treasury stock $ (3) 2,157,225 (2,157,222)
Cancellation of treasury stock, shares   (3,176)        
Net income (loss) 25,530,961 56,453 25,474,508
Issuance of common stock through warrant exchange agreement          
Balance at Dec. 31, 2021 55,863,239 $ 2,545 124,476,447 56,453 (68,672,206)
Balance, shares at Dec. 31, 2021   2,545,220        
Stock-based compensation 1,282,757 1,282,757
Restricted common stock grant $ 36 (36)
Restricted common stock grant, shares   35,750        
Restricted common stock forfeitures $ (3) 3
Restricted common stock forfeitures, shares   (3,250)        
Issuance of common stock under rule 144 restrictions related to contemplated spin-off transaction $ 25 (25)
Issuance of common stock through registered direct offering at $3.095 per share and accompanying warrants (net of offering expenses and placement agent discount), shares   25,000        
Repurchase and cancellation of common stock (4,026,523) $ (186) (4,026,337)
Repurchase and cancellation of common stock, shares   (186,299)        
Net income (loss) (18,873,758) 407,933 (19,281,691)
Distribution to noncontrolling interest in consolidated subsidiary (15,692) (15,692)
Issuance of common stock through warrant exchange agreement $ 4,495,500 304 4,495,196
Issuance of common stock through warrant exchange agreement, shares 303,750          
Loss on redemption of Series A and Series B Preferred Stock $ (2,385,000) (2,385,000)
Balance at Dec. 31, 2022 $ 36,340,523 $ 2,721 $ 127,869,342 $ 448,694 $ (91,980,234)
Balance, shares at Dec. 31, 2022   2,720,171